Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights.

Launch date

2014

Employees

Market cap

Enterprise valuation

AUD28m (Public information from Sep 2023)

Cambridge Massachusetts (HQ)

http://surfaceoncology.com

https://twitter.com/surfaceoncology https://www.linkedin.com/company/surface-oncology/

Authorizing premium user...